Mangoceuticals (MGRX) Liabilities and Shareholders Equity (2022 - 2026)
Mangoceuticals (MGRX) posted Liabilities and Shareholders Equity of $14.4 million for Q1 2026, down 10.2% sequentially from $16.1 million in Q4 2025, and down 33.58% YoY from $21.8 million in Q1 2025.
Mangoceuticals (MGRX) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
Mangoceuticals has reported Liabilities and Shareholders Equity for 5 years, with the latest figure at $14.4 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 33.58% year-over-year to $14.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.9 million (up 1.13% YoY) and the FY2025 annual result came in at $16.1 million, up 4.68% from the prior year.
- Liabilities and Shareholders Equity retreated to $14.4 million in Q1 2026 per MGRX's latest filing, from $16.1 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $21.8 million in Q1 2025 and troughed at $301447.0 in Q1 2024.
- A 5-year average of $10.5 million and a median of $14.6 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity sank 92.67% in 2024, then soared 7116.48% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $1.0 million in 2022, then increased by 4.74% to $1.1 million in 2023, then surged by 1362.75% to $15.4 million in 2024, then grew by 4.68% to $16.1 million in 2025, then declined by 10.2% to $14.4 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $14.4 million, $16.1 million, and $16.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 9.13 Bn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 5.99 Bn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 3.31 Bn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 1.03 Bn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 827.40 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 4.63 Bn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 5.87 Bn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 1.08 Bn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 344.46 Mn |
| 10 | Mangoceuticals | 9.55 Mn | 9.30 Mn | 44,215.00 | 14.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.17 Mn |
| Mar 31, 2026 | 14.45 Mn |
| Dec 31, 2025 | 16.09 Mn |
| Sep 30, 2025 | 16.53 Mn |
| Jun 30, 2025 | 20.84 Mn |
| Mar 31, 2025 | 21.75 Mn |
| Dec 31, 2024 | 15.37 Mn |
| Sep 30, 2024 | 14.79 Mn |
| Jun 30, 2024 | 15.24 Mn |
| Mar 31, 2024 | 301,447.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 4.12 Mn |
| Dec 31, 2022 | 1.00 Mn |